Cleo Diagnostics Ltd (ASX:COV)
0.2750
+0.0050 (1.85%)
Nov 17, 2026, 10:23 AM AEDT
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 37.71 million as of November 16, 2026. It is the 35,061st most valuable company in the world and the 858th biggest in Australia. Its market cap has decreased by 45.66% in one year.
Market Cap
37.71M
Enterprise Value
31.48M
Revenue
1.72M
Global Rank
Country Rank
#858 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 37.71M, an increase of 46.72%. That is a compound annual growth rate of 12.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 37.71M | -54.46% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 68.02M |
| Epiminder | 59.58M |
| Cyclopharm | 57.84M |
| Saluda Medical | 50.40M |
| Compumedics | 48.94M |
| Nova Eye Medical | 45.59M |
| HeraMED | 40.55M |
| CleanSpace Holdings | 38.10M |